Rensis Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Ahmedabad, Gujarat, India, established in 2020.

2020 Ahmedabad, Gujarat, India Struck Off

Last Updated: July 23, 2025

About Rensis Pharmaceuticals Private Limited

Rensis Pharmaceuticals Private Limited, a struck off private limited company, was established on 15 September 2020 in Ahmedabad, Gujarat, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233GJ2020PTC116539. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Rajesh Kumar (Director), Pankaj Kumar Kumawat (Director), Sunil Kumar Jakhar (Director). It is based at A/107 Ratnaraj Greens, B/M Cng Petrol Pum, Nana Chiloda, Ahmedabad, Gujarat, 382330.

Company Details

CIN/LLPIN
U24233GJ2020PTC116539
Registration Number
116539
Incorporation Date
15 September 2020
Authorized Capital
₹1.00 M
Paid-Up Capital
₹1.00 M
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 1.00 M as on 23-07-2025
Paid Up Capital ₹ 1.00 M as on 23-07-2025
Company Age 5 Year, 6 Months

Comprehensive Company Insights

Explore comprehensive insights into Rensis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Rensis Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rajesh Kumar	Director	15 Sep 2020	Current
Pankaj Kumar Kumawat	Director	15 Sep 2020	Current
Sunil Kumar Jakhar	Director	15 Sep 2020	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rensis Pharmaceuticals.

Enhance accessibility to Rensis Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rensis Pharmaceuticals?

Unlock access to Rensis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rensis Pharmaceuticals?

Rensis Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Rensis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rensis Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rensis Pharmaceuticals

Recent Activity within the Organization

Director Appointment

Rajesh Kumar was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
15 Sep 2020
Director Appointment

The activity Pankaj Kumar Kumawat was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 6 months . was completed.
15 Sep 2020
Director Appointment

Progress on Sunil Kumar Jakhar was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 6 months . was documented.
15 Sep 2020
Company Incorporation

Progress on Rensis Pharmaceuticals Private Limited was registered on 15 Sep 2020 with Roc Ahmedabad & aged 5 years 6 months as per MCA records. was documented.
15 Sep 2020

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Rensis Pharmaceuticals Private Limited?

The CIN of Rensis Pharmaceuticals Private Limited is U24233GJ2020PTC116539.

Where is Rensis Pharmaceuticals Private Limited headquartered?

Rensis Pharmaceuticals Private Limited is headquartered at A/107 Ratnaraj Greens, B/M Cng Petrol Pum, Nana Chiloda, Ahmedabad, Gujarat, 382330.

When was Rensis Pharmaceuticals Private Limited incorporated?

Rensis Pharmaceuticals Private Limited was incorporated on 15 September 2020.

Who are the current directors of Rensis Pharmaceuticals Private Limited?

The current directors of Rensis Pharmaceuticals Private Limited are

What is the primary industry of Rensis Pharmaceuticals Private Limited?

The primary industry of Rensis Pharmaceuticals Private Limited is Chemicals.

Is Rensis Pharmaceuticals Private Limited a listed company?

Rensis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Rensis Pharmaceuticals Private Limited?

The authorized capital of Rensis Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available